Sichuan Goldstone Asia Pharmaceutical Inc. (300434.SZ) SHZ

13.13

+1.15(+9.60%)

Updated at November 14 01:24PM

Currency In CNY

Valuation

Market Cap3.29B
Enterprise Value2.95B
P/E Ratio43.51
PEG Ratio0.5
Price/Sales Ratio4.8
Price/Book Ratio2.07
Enterprise/Revenue4.54
Enterprise/EBITDA34.78

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin0.11
Operating Margin0.13

Management Effectiveness

Return On Assets0.04
Return On Equity0.05

Income Statement

Revenue1.1B
Revenue/Share2.67
Gross Profit633.14M
EBITDA228.51M
Net Income91.76M
Diluted EPS0.23

Balance Sheet

Total Cash432.88M
Total Cash/Share1.08
Total Debt131.31M
Total Debt/Equity0.05
Current Ratio2.42
Book Value Per Share6.24

Price History

52-Week Change38.34
52-Week High12.93
52-Week Low6.71
Moving Average 50 Days10.32
Moving Average 200 Days9.55

Statistics

Average Volume17.64M
Shares Outstanding401.74M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.07
Trailing Annual Dividend Yield0.54
Payout Ratio0.24
Last Split Factor9:5
Last Split DateOctober 12, 2018